PRAXIS PRECISION MEDICINES ANNOUNCES POSITIVE RESULTS FROM EMBOLD STUDY FOR RELUTRIGINE IN SCN2A AND SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES

Reuters · 23h ago

Please log in to view news